Find uplifting stories about heroes, innovations, and solutions
46 results for "glioblastoma"
A $50,000 grant is helping Canadian researchers unlock why the deadliest brain cancer resists treatment that works for other cancers. The early-stage work could lead to the first effective immunotherapy for glioblastoma patients.
Scientists at UCLA built miniature 3D brain models that reveal why the deadliest brain cancer resists treatment, opening doors to personalized therapies. These lab-grown organoids mimic real human brains, showing for the first time how tumors communicate with healthy cells to become more aggressive.
Scientists at McMaster University discovered how deadly glioblastoma grows and identified an existing HIV medication that could fight it. The breakthrough could fast-track treatment for patients who currently have few options.
Scientists at the University of Virginia have discovered a pill that stops glioblastoma, the deadliest brain cancer, from spreading in lab mice without harmful side effects. The breakthrough targets a gene that drives the cancer's aggressive spread through the brain.
Patients with glioblastoma, the most aggressive form of brain cancer, finally have new hope. Boston researchers just proved a genetically modified virus can extend survival by helping the immune system attack tumors.
A groundbreaking immune cell therapy caused aggressive brain tumors to shrink dramatically within days in early trials. The treatment offers new hope for glioblastoma, one of the deadliest cancers with few effective options.
Scientists used a genetically modified herpes virus to help immune cells attack glioblastoma, the deadliest brain tumor. Patients in the trial lived longer than expected, offering new hope after 20 years without treatment advances.
A startup is bringing hope to glioblastoma patients with an experimental CAR-T therapy that made all three initial patients' tumors shrink dramatically. One patient remains cancer-free more than 2.5 years after treatment.
A personalized vaccine safely triggered immune responses in patients with glioblastoma, one of the most aggressive brain cancers. The early trial offers fresh hope for a disease that typically gives patients less than 18 months to live.
A single injection of an engineered virus is finally unlocking the immune system's power against glioblastoma, one of the deadliest brain cancers. Patients treated with the virus lived longer than expected, offering hope after 20 years without new treatment options.
Scientists have developed a gene therapy that completely eliminated aggressive brain tumors in 83% of animal trials, with no recurrence over 11 months. The breakthrough treatment for glioblastoma, the deadliest brain cancer, uses a "Trojan horse" approach that kills cancer cells while training the immune system to fight back.
Researchers at Brown University Health have discovered a molecule that could revolutionize treatment for glioblastoma, one of the deadliest brain cancers. The breakthrough explains why some tumor cells resist chemotherapy while others don't.
Scientists created a nanofiber mesh that delivers three cancer drugs directly to brain tumors, doubling survival time in mice with glioblastoma. The breakthrough offers hope for treating one of the deadliest cancers.
A small trial in Calgary found that high-dose vitamin B3 helped 82% of glioblastoma patients avoid disease progression for six months, compared to the typical 54%. While early and requiring more study, the affordable supplement appears to rejuvenate immune cells to better fight this aggressive cancer.
Becca Valle was given months to live after a glioblastoma diagnosis, but a breakthrough ultrasound treatment helped her become part of a rare 10% who survive past five years. The experimental therapy could transform how doctors treat deadly brain cancers.
A breakthrough gene therapy wiped out aggressive brain tumors in 83% of cases with a single dose and no side effects for nearly a year. The treatment also taught the immune system to prevent the cancer from returning.
After losing his dad to brain cancer and surviving testicular cancer himself, Adam Averback is running the Boston Marathon to raise awareness and honor his father's memory. He's been training through a blood infection and liver abscess that would have stopped most people.
A decade after Gillian Lee's brain tumor diagnosis, her family donated £50,000 to fund groundbreaking immunotherapy research that could transform treatment for aggressive brain cancers. The gift honors a woman who turned her diagnosis into inspiration for others to truly live.
A new immunotherapy developed at McMaster University has successfully eliminated deadly glioblastoma tumors in preclinical trials, offering hope for a cancer that has had no major treatment advances in 20 years. The therapy could enter human trials soon.
A personalized DNA vaccine for glioblastoma, one of the deadliest brain cancers, doubled survival rates in early trials and kept one patient cancer-free for nearly five years. The vaccine trains each patient's immune system to recognize up to 40 unique cancer proteins, making it harder for tumors to hide.
Showing 20 of 46